The U.S. Supreme Court declined on Monday to hear a pharmaceutical industry challenge to a plan ​to curb Medicare drug prices adopted during Democratic former President Joe Biden's administration that drugmakers argued ‌illegally forces them to accept steep discounts and jeopardizes innovation.